அதிகமானது பாரிஸ் பல்கலைக்கழகம் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அதிகமானது பாரிஸ் பல்கலைக்கழகம் மருத்துவமனைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அதிகமானது பாரிஸ் பல்கலைக்கழகம் மருத்துவமனைகள் Today - Breaking & Trending Today

Identifying genomic subtypes of pancreatic cancer from histology slides using AI-based tool

AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021. ....

Saint Antoine , France General , Julien Calderaro , Gilles Wainrib , Gustave Roussy , Robert Debr , Ligue Contre Le , Jean Pierre Hugot , Emily Henderson , Nature Communications , Greater Paris University Hospitals , Paris University Hospitals , Federated Learning , Chief Scientific Officer , Beaujon Hospital , Amboise Par , Des Tumeurs De La Ligue Contre , Paris University , Pancreatic Adenocarcinoma , Pancreatic Cancer , Clinical Trial , Deep Learning , Machine Learning , Medical Research , துறவி அன்டோயின் , பிரான்ஸ் ஜநரல் ,

First AI-based tool for predicting genomic subtypes of pancreatic cancer from histology slides


 E-Mail
Paris, France and New York, NY June 10, 2021 - AP-HP Greater Paris University Hospitals, the leading European clinical trial center with the largest amount of healthcare data in France dedicated to research and Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announced the recent results of their ongoing strategic collaboration at ASCO 2021. The abstract and poster entitled Identification of pancreatic adenocarcinoma molecular subtypes on histology slides using deep learning models demonstrates the first AI-based
tool for predicting genomic subtypes of pancreatic cancer (PDAC) developed from machine learning applied to histology slides. The tool, a trained and validated AI model, is usable in clinical practice worldwide and opens the possibility of patient molecular stratification in routine care and for clinical ....

New York , United States , Saint Antoine , France General , Julien Calderaro , Robert Debr , Ligue Contre Le , Gilles Wainrib , Thomas Clozel , Gustave Roussy , Talia Lliteras , Jean Pierre Hugot , Nature Communications , Ongoing Fruitful Research Collaboration , Greater Paris University Hospitals , Paris University Hospitals , Federated Learning , Chief Scientific Officer , Beaujon Hospital , Amboise Par , Des Tumeurs , Paris University , Ongoing Fruitful Research , Pancreatic Adenocarcinoma , Medicine Health , Clinical Trials ,

Phase II Research Against COVID-19 Launched In France With Debiopharm's Antiviral Alisporivir


Share this article

Pre-clinical in vitro research from the Mondor Institute of Biomedical Research (INSERM U955) has shown evidence for the effectiveness of alisporivir against the replication of
SARS-COV-2 (COVID-19)
-
A randomized, investigator-initiated, phase II study, conducted by the AP-HP (Greater Paris University Hospitals), has been launched to assess the efficacy and safety of the compound in 90 hospitalized COVID-19 patients from multiple centers in France
-
Debiopharm has opted to forgo any financial benefit from treatment and pledges to donate all proceeds to a non-profit foundation dedicated to infectious disease research
LAUSANNE, Switzerland, Jan. 18, 2021 /PRNewswire/
 Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company,  ....

France General , Bertrand Ducrey , Jean Michel Pawlotsky , Prnewswire Debiopharm , Pathology Department , Mondor Institute Of Biomedical Research , Debiopharm International , Greater Paris University Hospitals , Henri Mondor Hospital Group , Mondor Institute , Biomedical Research , Greater Paris University , Henri Mondor Hospital , Swiss Biotech Success Story , Debiopharm International Sa , பிரான்ஸ் ஜநரல் , நோயியல் துறை , மோந்டோர் நிறுவனம் ஆஃப் உயிர் மருத்துவ ஆராய்ச்சி , அதிகமானது பாரிஸ் பல்கலைக்கழகம் மருத்துவமனைகள் , ஹென்றி மோந்டோர் மருத்துவமனை குழு , மோந்டோர் நிறுவனம் , உயிர் மருத்துவ ஆராய்ச்சி , அதிகமானது பாரிஸ் பல்கலைக்கழகம் , ஹென்றி மோந்டோர் மருத்துவமனை , சுவிஸ் பயோடெக் வெற்றி கதை ,